Antiplatelet therapy in the management of atherothrombosis: recent clinical advances

Blood Adv. 2018 Jul 24;2(14):1806. doi: 10.1182/bloodadvances.2018005074.

Authors

Noel C Chan¹, Jeffrey I Weitz¹

Affiliation

¹ Department of Medicine and Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.

No abstract available

MeSH terms

Aspirin / therapeutic use*
Atherosclerosis / drug therapy*
Atherosclerosis / etiology
Atrial Fibrillation / surgery*
Humans
Percutaneous Coronary Intervention / adverse effects*
Platelet Aggregation Inhibitors / therapeutic use*
Postoperative Complications / drug therapy*
Receptors, Purinergic P2Y12
Rivaroxaban / therapeutic use*
Thrombosis / drug therapy*
Thrombosis / etiology

Substances

P2RY12 protein, human
Platelet Aggregation Inhibitors
Receptors, Purinergic P2Y12
Rivaroxaban
Aspirin